SAN FRANCISCO, Jan. 5, 2018 /PRNewswire/ — Alveo Technologies, Inc., (“Alveo” or “the Company”) whose mission it is to create affordable and accessible infectious disease diagnostic devices, announced the closing of a $38 million Series A financing raised by Maxim Merchant Capital, a…
